This inventor holds 3 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Daiichi Sankyo Company, Limited, Ono Pharmaceutical Co., Ltd., Other. Active years: 2009-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Toyonaka-shi, Osaka, JP (2009)
- Toyonaka, JP (2010 - 2016)
Company Filing History:
2 out of 462 
1 out of 575 
1 out of 834,513 Years Active: 2009-2016
Title: Discovering the Innovations of Iichiro Shimomura
Introduction: Iichiro Shimomura is a prominent inventor based in Toyonaka, Japan. With a total of three patents to his name, his work focuses primarily on enhancements to pharmaceutical compositions that aid in metabolic processes. His significant contributions to the field have established him as a notable figure in innovative healthcare solutions.
Latest Patents: One of Iichiro Shimomura's latest patents is titled "Adiponectin Production Enhancer." This invention provides a pharmaceutical composition designed to enhance adiponectin production, thereby offering treatment or prevention of hypoadiponectinemia. The active ingredient in this formulation is an HMG-CoA reductase inhibitor. Another recent patent, "Method for Enhancing Glucose Uptake into Warm-Blooded Animal Adipocytes," focuses on a pharmaceutical composition that enhances glucose uptake in warm-blooded animal cells. This invention is aimed at the treatment of diabetes and its complications, particularly those arising from insulin resistance syndrome.
Career Highlights: Iichiro Shimomura has had a successful career, having contributed to major pharmaceutical companies such as Daiichi Sankyo Company, Limited and Ono Pharmaceutical Co., Ltd. His work at these institutions has played a crucial role in advancing pharmaceutical science, focusing on metabolic health and innovative treatment solutions.
Collaborations: Throughout his professional journey, Shimomura has collaborated with esteemed colleagues, including Yuji Matsuzawa and Tohru Funahashi. These partnerships have fueled collaborative research efforts resulting in impactful inventions aimed at addressing critical health issues.
Conclusion: In summary, Iichiro Shimomura stands out as an inventive force in the pharmaceutical industry. His latest patents reflect a commitment to improving health outcomes, particularly in the areas of diabetes and metabolic regulation. With his collaboration with industry leaders, Shimomura continues to contribute significantly to innovative advancements that have the potential to transform healthcare practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile